Sven holds an MSc in Cell and Gene Therapy from University College London, where he conducted research on lentiviral gene therapy for a rare disease. Before this, Sven wrote his thesis at IQVIA for his MSc in Health Economics from Erasmus University Rotterdam and worked as an innovation scout at Venture IQ. During his BSc Bio-Pharmaceutical Sciences at Leiden University, he gained experience at uniQure and at the Centre for Human Drug Research. Prior to joining Curie Capital, Sven completed an internship at Van Lanschot Kempen Investment Banking.